Minerva Neurosciences, Inc (NERV) Stock Price

4.18 ▲ +0.40 (+10.58%)
Open: 3.80 Vol: 36.54K Day's range: 3.80 - 4.205 Nov 28, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
NERV Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 3.84▼ 3.84▼ 3.84▲ 3.89▲ 4.03▲
MA10 3.83▲ 3.83▲ 3.85▼ 4.09▲ 3.39▲
MA20 3.84▲ 3.92▼ 4.00▼ 3.97▲ 2.76▲
MA50 4.04▼ 4.13▼ 4.10▼ 3.37▲ 2.20▲
MA100 4.16▼ 4.05▼ 3.98▼ 2.72▲ 2.87▲
MA200 4.08▼ 4.16▼ 3.95▼ 2.20▲ 4.09▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.018▲ 0.005▲ -0.015▼ -0.064▼ 0.188▲
RSI 42.646▼ 40.250▼ 40.330▼ 56.218▲ 67.133▲
STOCH 62.605     37.436     17.668▼ 25.837     20.718    
WILL %R -52.941     -85.185▼ -86.207▼ -43.299     -78.632▼
CCI 64.740     -28.040     -51.081     15.001     50.603    
Latest Filters Detected On NERV
RSI $NERV RSI(14) Crossed Above 50 Set Alert
MA $NERV Price Crossed Above MA(26) Set Alert
MA $NERV Price Crossed Above MA(13) Set Alert
MA $NERV Price Crossed Above MA(7) Set Alert
CDL $NERV Marubozu Candlestick Pattern Detected Set Alert
Minerva Neurosciences, Inc News
Autonomix Medical, Inc. Announces Pricing of $5.0 Million Private Placement Priced At The Market Under Nasdaq Rules
Wednesday, November 26, 2025 04:14 PM
Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced that it has entered into a ...
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment Highlighting Continued Execution and Strategic Growth
Wednesday, November 26, 2025 05:54 AM
The CEO Corner segment is now available here. Autonomix is a medical device company focused on advancing innovative technologies to revolutionize how diseases involving the nervous system are ...
NervGen Pharma Closes US $10 Million Private Placement Financing to Support Anticipated Nasdaq Listing and Advance NVG-291 Development
Friday, November 21, 2025 08:28 AM
NervGen Pharma Closes US $10 Million Private Placement Financing to Support Anticipated Nasdaq Listing and Advance NVG-291 Development ...
NERV historical stock data
date open high low close volume
28/11/25 3.80 4.205 3.80 4.18 36,538
26/11/25 3.79 3.94 3.76 3.78 26,400
25/11/25 3.77 3.96 3.759 3.77 29,500
24/11/25 3.95 4.10 3.78 3.78 59,400
21/11/25 4.31 4.31 3.93 3.94 42,700
20/11/25 4.30 4.385 4.11 4.34 72,700
19/11/25 4.20 4.42 4.14 4.30 40,900
18/11/25 4.30 4.38 4.07 4.30 177,558
17/11/25 4.17 4.60 3.90 4.36 319,100
14/11/25 3.75 4.21 3.75 4.11 89,929
Quote Details
52wk Low:1.15
52wk High:12.46
Vol:36.54K
Avg Vol(3m):61.8M
1Y Chng:+78.63%
1M Chng:+67.87%
Add to Watch List
More Information
Index US Composite
Market Cap. 26.92M